In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
about
Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagentLiposome-mediated transfection of wild-type P53 DNA into human prostate cancer cells is improved by low-frequency ultrasound combined with microbubbles.The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers.Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation.Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency.Viral and nonviral delivery systems for gene deliveryLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesCoating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.Gene therapy in orthopaedic surgery: the current status.The design and exogenous delivery of siRNA for post-transcriptional gene silencing.Novel molecular approaches to cystic fibrosis gene therapy.Delivery of antiangiogenic agents for cancer gene therapy.Long-circulating polymeric nanovectors for tumor-selective gene delivery.Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.Gene therapy for disorders affecting children, progress and potential.Targeting tumors using nanoparticle platforms: a phase I study of a systemically administered gene therapy system.Chemical activation of lipoplexes formed from DNA and a redox-active, ferrocene-containing cationic lipid.Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.Drug releasing systems in cardiovascular tissue engineering.Layered double hydroxide nanoparticles in gene and drug delivery.Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.An update on RNA interference-mediated gene silencing in cancer therapy.siRNA: novel therapeutics from functional genomics.Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells.Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery.Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.Pre-treatment with a non-therapeutic dose of cisplatin increases solid tumour response to liposomal-p53 gene therapy- An in vivo study.Mechanistic Insight into Sonoporation with Ultrasound-Stimulated Polymer Microbubbles.Gene Therapy in the Nervous System: Failures and Successes.Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles.Anionic liposomal delivery system for DNA transfection.Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals.Construction and application of a novel hepatocyte-directed vector to simultaneous knockdown and overexpression of multiple genes.Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy studyTransfection of myeloid leukaemia cell lines is distinctively regulated by fibronectin substratum.
P2860
Q28648083-223A88E9-2BA2-45C7-9996-B8A0D9F166ECQ30381308-2CF21CCF-BC08-411D-84B9-3A36A00598C0Q33273936-F28676AB-CA65-4E2A-AEA3-3B4A7037B858Q33816969-3016D337-48DC-47B7-B0FB-3E5D931F85C4Q34115911-285DC620-E7FB-42DF-9437-7AA609949320Q34146469-3B2C6F16-2EF6-4C8A-BEEE-D25E48E7E47AQ34315475-70D47341-C44D-4452-B253-2B721434D444Q34467839-68C64521-8B21-4490-A792-30753A8AB72FQ35476018-6E53556F-AACF-4B25-AED1-9209552E6DF4Q35630146-7AE8C655-C956-4F93-A1F4-CAE69A3888EAQ35950928-BDE40F7E-FBE0-4880-9023-68EE9BF5737DQ36012920-8ECF480C-7009-4663-9B11-F933997FB780Q36200143-DC80C27D-55D0-4813-B746-5EC19023B040Q36314788-66484BB7-247A-48C3-998A-85E1E0138B91Q36474300-01723C6A-41FF-4EBE-BBDF-CBBAAE6835E0Q36798836-2C1E57E6-C557-4C1C-AD8B-EDAB1DD9AF6CQ36816069-CBAD8544-B92E-4669-8294-21269695B55BQ36883899-290BA809-2BBA-4374-BDA1-2F92D1F4AA2BQ37105021-90A38EA4-A11E-4056-9171-6AFB0606D05FQ37378486-C8E20D47-AF09-4F7E-B917-CC2926788E9BQ37451635-BEB7475D-C1AC-471D-B3F8-1362989D312CQ37580918-1B4437A4-72D9-40D4-AF4E-20421CB2B610Q37798545-37CC7F7E-5452-46F3-8A9C-7DFD1FBC07B9Q38150118-3140C35E-179F-49B8-87DA-8F72BC63C4F9Q38227931-DC4A1585-C6E5-4165-B2DF-5193680463EDQ38229425-9D37B07F-C709-4B84-B127-A5B5B46B32DDQ38514695-B06464F9-F071-427F-82CC-2064B1920657Q38920821-DB1EAC93-443D-4131-891A-F84285A7B92FQ38963532-CBCFCD95-5E8B-4841-B2D7-927A4D69B500Q39630019-D16C5F4F-48F8-40F1-AEAC-677B4DCB86AAQ40067662-9F881F0A-052E-430F-A443-0D5E4DA2A861Q40070708-810B2D53-3B53-4C48-9721-BF013D61DBB4Q40436528-0C9E2E75-E9D1-49C7-936E-EDEB9FD10CF1Q40485168-07F146E0-16E9-47BC-B254-8BFF8DB615BAQ41534366-B7132B37-9C1C-461B-80EA-3220666C93D8Q42142908-70CC83FF-47C5-444D-832B-C74E0CC54A29Q42259491-33E53BFE-A40B-4485-81FD-405B77E019C4Q42262496-F23B96DD-FDAF-4DBB-996C-2126E2A93B3BQ42562759-7B46DBAC-1F28-494C-8FF9-96B41C734F61Q42951479-C0F56F16-1B13-4B44-A874-4286FED47513
P2860
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@ast
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@en
type
label
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@ast
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@en
prefLabel
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@ast
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@en
P2093
P356
P1476
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
@en
P2093
Dick Hoekstra
Lou F M H de Leij
Sandrine A L Audouy
P304
P356
10.1023/A:1020989709019
P577
2002-11-01T00:00:00Z